Key Dates

Related Announcements

• October 3, 2023 - Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed). See NOFO RFA-CA-23-039.
• October 3, 2023 - Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed). See NOFO RFA-CA-23-040.

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold two back-to-back pre-application webinars on two recently published Notice of Funding Opportunities (NOFOs) for the Human Tumor Atlas Network (HTAN) program. Both webinars will also provide a broad overview of HTAN. All potential applicants (new and incumbents) are encouraged to attend the webinars.

The webinars are scheduled on November 9, 2023, from 2:00 – 4:00 PM EST:

• 2:00 – 3:00 PM EST: RFA-CA-23-040: Human Tumor Atlas Network (HTAN): Precancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed)

Meeting Registration Link: https://cbiit.webex.com/weblink/register/rd357f5d0a1499fef4fe170204f6d047e

• 3:00 – 4:00 PM EST: RFA-CA-23-039: Human Tumor Atlas Network (HTAN): Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed)

Meeting Registration Link: https://cbiit.webex.com/weblink/register/r1441278cc13590c7ad759773070e1730

Attendees should register separately for the two webinars if they are interested in attending both.

Potential applicants should peruse the NOFOs prior to attending the webinar, and those interested in developing precancer atlases should attend both webinars.

Shortly after the webinars, the recordings will be made available on: https://www.cancer.gov/about-nci/organization/dcb/news/past-events

For RFA-CA-23-039, potential applicants are encouraged to submit their questions at NCI_HTAN_HTAU2C@mail.nih.gov by November 07, 2023.

For RFA-CA-23-040, potential applicants are encouraged to submit their questions at NCI_HTAN_PCAU2C@mail.nih.gov by November 07, 2023.

Participation in the webinar meeting, although encouraged, is optional and is not required for the submission of an application in response to these NOFOs.

Inquiries

Please direct all inquiries to:

NCI HTAN Team 
National Cancer Institute (NCI)
E-mail for RFA-CA-23-039: NCI_HTAN_HTAU2C@mail.nih.gov 
E-mail for RFA-CA-23-040: NCI_HTAN_PCAU2C@mail.nih.gov